
18/06/2025
Twice a year injectable PrEP for HIV prevention has just been FDA approved.
PrEP4All calls on Gilead to, for once, commit explicitly to a US pricing strategy that will actually lead to more equitable access
Read Our Statement Here:
The long-anticipated approval of lenacapavir as a once every six-month injectable option for PrEP is a welcome development in the fight to end HIV as an epidemic. It is also a testament to the value…